Chang Xu

4PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 19, 2025
Efficacy observation of sequential TAS-102 following regorafenib as a later-line treatment in patients with metastatic colorectal cancer: a cohort study.

Chang Xu, Xiangyu Cheng, Changqing Liu

|Dec 23, 2024
A multicenter retrospective study of the combination of immune checkpoint inhibitors and chemotherapy regimens with or without liver metastasis for the first-line treatment of advanced gastric cancer.

Jing Ren, Ke Wang, Qianhao Meng

|Nov 24, 2024
Integrated single-cell transcriptome and TCR profiles of hepatocellular carcinoma highlight the convergence on interferon signaling during immunotherapy.

Tianhao Li, Shengnan Guo, Chang Xu

|Nov 19, 2024
A comparison between single and fractionated doses of albumin-bound paclitaxel in the treatment of advanced esophageal cancer: A multicenter case-control study.

Jing Ren, Ke Wang, Jian Zhao

Pageof 1

Frequent Collaborators

4 joint publications

Guangyu Wang

3 joint publications

Jing Ren

2 joint publications

Ke Wang

2 joint publications

Changqing Liu